Halozyme Therapeutics HALO
NASDAQ HALO
$125.63 +1.09 (+0.88%)
At close: Oct 23, 2026 · 4:00 PM EDT

Halozyme Therapeutics (HALO) Sale and Maturity of Investments (2014 - 2026)

Updated

Analysis

Halozyme Therapeutics (HALO) Sale and Maturity of Investments (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Halozyme Therapeutics 14.33 Bn 12.93 Bn 401.83 Mn 53.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 53.27 Mn
Mar 31, 2026 9.00 Mn
Sep 30, 2025 209.60 Mn
Jun 30, 2025 189.11 Mn
Mar 31, 2025 50.17 Mn
Sep 30, 2024 138.01 Mn
Jun 30, 2024 53.96 Mn
Mar 31, 2024 119.63 Mn
Sep 30, 2023 81.19 Mn
Jun 30, 2023 53.37 Mn
Mar 31, 2023 61.13 Mn
Dec 31, 2022 20.13 Mn
Jun 30, 2022 590.00 Mn
Mar 31, 2022 136.00 Mn
Dec 31, 2021 69.85 Mn
Sep 30, 2021 24.97 Mn
Jun 30, 2021 76.86 Mn
Mar 31, 2021 76.00 Mn
Dec 31, 2020 124.62 Mn
Sep 30, 2020 53.21 Mn
API Access

Halozyme Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=HALO&period=max&api_key=YOUR_API_KEY